The Prescription Information Modernization Act of 2025 aims to update how prescribing information for drugs, including biological products, is communicated. The main goal is to allow this information to be shared digitally, making it more accessible and efficient for healthcare providers. One of the key provisions of this legislation is that manufacturers can provide required prescribing information solely through electronic means. However, they must also offer prescribers and dispensers the option to receive this information in paper form if they prefer.